Skip to main content
DeutschDE
European Commission logo print header
Inhalt archiviert am 2024-04-15

GENETICALLY ENGINEERED VACCINES AGAINST PORCINE AND BOVINE HERPESVIRUSES

Ziel

OBTENTION OF NEW VACCINES AGAINST HERPESVIRUSES AFFECTING PORCINE AND BOVINE (AUJESKI'S DISEASE AND INFECTIOUS BOVINE RHINOTRACHEITIS).
Vaccinia virus was used as a vector for glycoproteins gI, gIV and gH of bovine herpesvirus type 1 (BHV-1). Cattle vaccinated with these recombinant viruses were not protected against challenge with virulent BHV-1. Thus, these glycoproteins expressed by a heterologous viral vector provided insufficient immunity. Five distinct antigenic sites were found on gII of pseudorabies virus (PRV), 3 of which were located close to the transmembrane region. The gII gene was inserted into vaccinia virus and this recombinant virus induced neutralising antibodies in pigs. Six different epitopes were localised on gI of PRV, of which 3 were discontinuous. The amino acid sequences of the 3 continuous epitopes were determined. The discontinuous epitopes appeared to be the most immunogenic in pigs. Tests to detect antiboides to gI must include the discontinuous epitopes.
AT THE PRESENT STAGE OF HERPESVIRUS RESEARCH THERE IS HOPE THAT SUBUNIT VACCINES CONTAINING HERPESVIRAL GLYCOPROTEINS (GP), OR RECOMBINANT VACCINES EXPRESSING HERPESVIRAL GLYCOPROTEIN GENES WILL REPRESENT SAFE AND MORE EFFICIENT VACCINES. PRV AND BHV-1 PHYLOGENETICALLY CLOSELY RELATED VIRUSES AND PARTS OF THE GENOMES CROSS-HYBRIDIZE. THE EXPERIMENTAL STRATEGIES ARE CONVERGENT AND THEREFORE THE THREE GROUPS BELIEVE THAT CO-OPERATION WILL SPEED UP RESEARCH. THE PROJECT FOCUSSES ON THE (1) IDENTIFICATION OF GP'S, (2) ROLE OF INDIVIDUAL GP'S IN VIRULENCE AND IMMUNOGENICITY, (3) LOCALIZATION OF THEIR GENES TO BE FOLLOWED BY (4) ISOLATION OF GENES AND (5) INSERTION OF GP GENES IN APPROPRIATE RECOMBINANT VECTORS OR EXPRESSIONS SYSTEMS.

Wissenschaftliches Gebiet

Programm/Programme

Thema/Themen

Data not available

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

CSC - Cost-sharing contracts

Koordinator

FRIEDRICH-LOEFLER INSTITUTE FEDERAL RESEARCH INSTITUT FOR ANIMAL HEALTH
EU-Beitrag
Keine Daten
Adresse
Boddenblick 5 A
17498 INSEL RIEMS
Deutschland

Auf der Karte ansehen
Gesamtkosten
Keine Daten

Beteiligte (2)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 23 Januar 1994

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/BAP*0233/de

European Union, 2024